GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like SoCal's Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug June 11, 2017 The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More November 21, 2017 3 Best Biotherapeutics Stocks to Buy Right Now February 1, 2018
